期刊文献+

自体外周血树突状细胞诱导LAK细胞抗原代肝癌细胞的初步研究 被引量:1

Preliminary study of autogenous peripheral blood dendritic cells inducing LAK cells against origenal hepatocellullar cancer cells
下载PDF
导出
摘要 目的 :观察自体外周血树突状细胞(DC)诱导的淋巴因子激活杀伤 (LAK )细胞对原代肝癌细胞的杀伤活性。方法 :从肝癌患者外周血分离单个核细胞 ,以人粒 /巨噬细胞集落刺激因子 (GM CSF)和白细胞介素(IL ) 4诱导扩增DC ,以四甲基噻唑蓝(MTT )方法观察单独应用IL 2诱导的LAK细胞组和联合应用DC组对肝癌细胞的杀伤活性。结果 :联合应用DC组对肝癌细胞杀伤活性 [( 3 0 76± 1 44 ) % ]明显比单独应用LAK细胞组的活性 [( 18 2±1 2 9) % ]高 ,P <0 0 1。结论 :DC可以提高效应细胞对靶细胞的杀伤活性 。 OBJECTIVE:To study the activity killer of LAK cells against original hepatocellcullar cancer cells induced by autogenous peripheral blood dendritic cells(DC).METHODS:The DC from a hepatocell cancer patient was isolated and purified with combination of granulocyte/macrophage colony stimulating factor and interleukin 4;lymphokine activated killer cells were induced with interleukin 2;the activity killer of LAK cells against original HCC or LAK cells and DC against original HCC was observed by the MTT method.RESULTS:The activity killer of LAK cells and DC against original HCC[(30.76±1.44)%] was higher obviously than that of LAK cells alone[(18.2±1.29)%],P<0.01.CONCLUSTIONS:DC could improve the activity killer of effecting cells resisting target cells,implying that DC may be important in the therapy and prevention against hepatocellcullar cancer.
出处 《肿瘤防治杂志》 2004年第5期499-500,共2页 China Journal of Cancer Prevention and Treatment
关键词 肝细胞/免疫学 肝细胞/治疗 树突细胞 carcinoma,hepatocellular/immunology carcinoma,hepatocellular/therapy dendritic cells
  • 相关文献

参考文献7

二级参考文献36

  • 1Banchereau J, Steinman RM. Dendritic cells and the control of immunity[J]. Nature, 1998, 392:245-252.
  • 2Linda M, Liau MD, Keith L, et al. Treatment of intracranial gliomas with bone marrow- derived dendritic cells pulsed with tumor antigens[J]. J Neurosurg, 1999, 90(6) : 1115 - 1124.
  • 3Tjoa BA, Elgamal AA, Murphy GP, et al. Vaccine therapy for prostate canccr[J]. Urol Clin North Am, 1999,26(2) :365 -374.
  • 4Yoshida S, Morii K, Watanabe M, et al. The generation of anti- tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors[J]. Cancer Immunol Immunother, 2001,50(6) :321 - 327.
  • 5Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T - cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines[J]. Cancer Res, 2001,61 ( 17 ) :6445- 6450.
  • 6Ashley DM, Faiola B, Nair S,et al. Bone nmrtDw- generated dendritic cells pulsed with tumor extracts or tumor RNA induced antitumor immunity against central nervous system tumors[J]. J Exp Med, 1997, 186(7):1177- 1182.
  • 7Yu JS, Wheeler CJ, Zeltzer PM, et al. Vaccination of malignant glioma patients with peptide- pulsed dendritic cells elicits systemic cytotoxicity and intracranial T- cell infiltration[ J ].Cancer Res, 2001, 61(3):842-847.
  • 8Kalady MF, Onaitis MW, Padilla KM, et al. Enhanced dendritic cell antigen presentation in RNA- based immunotherapy[J]. J Surg Res, 2002, 105(1):17-24.
  • 9Schnurr M, Scholz C, Rothenfusser S, et al. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross - priming of cytotoxic T cells and activate NK and γδ T cells[J]. Cancer Res, 2002, 62 (8):2347- 2352.
  • 10Di Sabatino A, Ciccocioppo R, D'Alσ S, et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in celiac disease[J]. Gut, 2001, 49 (3):380-386.

共引文献38

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部